Sun Pharmaceutical Industries Ltd announces in a media release that one of its wholly owned subsidiaries presented further evidence of the long-term use and cost-effectiveness of ILUMYA (tildrakizumab-asmn) in moderate-to-severe plaque psoriasis at the American Academy of Dermatology (AAD) Virtual Meeting Experience 2020.
The AAFPRS Foundation Board announces it has cancelled the in-person gathering for the 2021 AAFPRS Annual Meeting in Las Vegas. Rather, it is hosting a virtual meeting on the same dates: September 29-October 2.
In this episode, Leah Garcia and Dr Felipe Jimenez of Nulastin, the hair care brand focused on elastin replenishment, on why hair care products should be part of a plastic surgery practice’s retail offerings and its line of products featuring its patented Elastaplex technology.
The ISHRS Virtual Congress will be held October 17-25, 2020, with in-depth scientific sessions covering a spectrum of the latest topics in hair transplantation.
Read MoreData from this study suggests that treatment with lebrikizumab provided rapid and clinically meaningful improvements in itch, sleep and overall measures of quality of life, according to a media release.
Read MoreAbbVie a research-based global biopharmaceutical company, announces new late-breaking Phase 3b head-to-head data showing superior rates of skin clearance for SKYRIZI (risankizumab-rzaa) to COSENTYX (secukinumab) at week 52, in a news release.
Read MoreJohnson & Johnson Consumer Health presented findings from a longitudinal study of infant and mother skin microbiome research at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2020, being held from June 12 – 14, 2020, according to a news release.
Read More
Soliton Inc will present the results from its pivotal cellulite trial through a virtual video presentation at the American Academy of Dermatology (AAD) 2020 Virtual Meeting, being held June 12-14, 2020 online, according to a news release.
Read More